SHORT AND LONG-TERM COST-EFFECTIVENESS OF SWITCHING THERAPY FROM INSULIN GLARGINE TO INSULIN DETEMIR IN PEOPLE WITH TYPE 2 DIABETES

被引：0
|
作者：
Malek, R. [1 ]
Galvez, G. G. [2 ]
Hammerby, E. [3 ]
Nikolajsen, A. [3 ]
Henriksen, O. [4 ]
Andersen, M. F. B. [4 ]
机构：
[1] CHU Setif, Setif, Algeria
[2] Inst Jalisciense Invest Diabet & Obesidad, Guadalajara, Jalisco, Mexico
[3] Novo Nordisk AS, Soborg, Denmark
[4] Last Mile PS, Copenhagen K, Denmark
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.2061
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A690 / A690
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF INSULIN DETEMIR IN PEOPLE WITH TYPE 2 DIABETES IN ROMANIA
    Ionescu-Targoviste, C.
    Wrona, W.
    Schubert, A.
    Niewada, M.
    Czech, M.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A500 - A500
  • [2] SHORT AND LONG-TERM COST-EFFECTIVENESS OF SWITCHING THERAPY FROM BIPHASIC HUMAN INSULIN 30 TO BIPHASIC INSULIN ASPART 30 IN PEOPLE WITH TYPE-2 DIABETES
    Home, P. D.
    Soewondo, P.
    Hussein, Z.
    Shafie, A. A.
    AlRaddady, K.
    Baadbad, R.
    Hammerby, E.
    Nikolajsen, A.
    Andersen, M. F. B.
    Henriksen, O.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A164 - A164
  • [3] Cost-effectiveness of insulin detemir versus insulin glargine for Thai type 2 diabetes from a payer's perspective
    Permsuwan, Unchalee
    Thavorn, Kednapa
    Dilokthornsakul, Piyameth
    Saokaew, Surasak
    Chaiyakunapruk, Nathorn
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (09) : 991 - 999
  • [4] Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand
    Unchalee Permsuwan
    Nathorn Chaiyakunapruk
    Piyameth Dilokthornsakul
    Kednapa Thavorn
    Surasak Saokaew
    [J]. Applied Health Economics and Health Policy, 2016, 14 : 281 - 292
  • [5] Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand
    Permsuwan, Unchalee
    Chaiyakunapruk, Nathorn
    Dilokthornsakul, Piyameth
    Thavorn, Kednapa
    Saokaew, Surasak
    [J]. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2016, 14 (03) : 281 - 292
  • [6] An analysis of the cost-effectiveness of starting insulin detemir in insulin-naive people with type 2 diabetes
    Home, Philip
    Baik, Sei Hyun
    Gonzalez Galvez, Guillermo
    Malek, Rachid
    Nikolajsen, Annie
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (03) : 230 - 240
  • [7] COST-EFFECTIVENESS OF SWITCHING PATIENTS WITH TYPE 2 DIABETES FROM INSULIN GLARGINE TO INSULIN DETEMIR IN A CHINESE SETTING: A HEALTH ECONOMIC MODEL BASED ON THE PREDICTIVE STUDY
    Yang, L.
    Christensen, T.
    White, J.
    Sun, F.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A5 - A5
  • [8] Cost-Effectiveness of Switching Patients with Type 2 Diabetes from Insulin Glargine to Insulin Detemir in Chinese Setting: A Health Economic Model Based on the PREDICTIVE Study
    Yang, Li
    Christensen, Torsten
    Sun, Fengyu
    Chang, Jinghua
    [J]. VALUE IN HEALTH, 2012, 15 (01) : S56 - S59
  • [9] SHORT AND LONG-TERM COST-EFFECTIVENESS OF STARTING BIPHASIC INSULIN ASPART 30 IN INSULIN-NAIVE PEOPLE WITH TYPE-2 DIABETES
    Home, P. D.
    Soewondo, P.
    Hussein, Z.
    Shafie, A. A.
    AlRaddady, K.
    Baadbad, R.
    Hammerby, E.
    Nikolajsen, A.
    Andersen, M. F. B.
    Henriksen, O.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A164 - A164
  • [10] SHORT-TERM COST-EFFECTIVENESS OF INSULIN DETEMIR VERSUS NPH INSULIN IN INSULIN-NAIVE SUBJECTS WITH TYPE 2 DIABETES IN SWEDEN
    Ridderstrale, M.
    Ericsson, A.
    Jensen, M. M.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A480 - A480
12345